Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a phase 1 study in which healthy adult volunteers will receive BRII-196 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.
Epistemonikos ID: 9736435aec5932fd8dc82207d834a682cb12e763
First added on: Jul 22, 2020